Navigation Links
Migraines' Frequency Influences Heart Attack, Stroke Risk
Date:4/17/2008

But the absolute risk to patients remains very low, expert says

THURSDAY, April 17 (HealthDay News) -- Women who have weekly migraines are at an increased risk for stroke compared to those with few or no migraines, a new study finds.

On the other hand, those with less frequent migraines may have an increased risk of heart attack, the same team of researchers report.

The findings, to be presented Thursday at the American Academy of Neurology annual meeting in Chicago, point to different mechanisms linking migraines to distinct cardiovascular troubles, experts say.

And even though the average migraine sufferer's absolute risk of a heart attack or stroke is still low, the new study should be viewed in the context of other cardiac risk factors, said Dr. Richard Lipton, vice chairman of neurology at Montefiore Headache Center in New York City.

"Someone with migraine should be sure to manage their other risk factors including high blood pressure, diabetes, smoking, high cholesterol and body weight," said Lipton. He was not involved in the study, which was conducted by a team from Brigham & Women's Hospital and Harvard Medical School in Boston.

Previous research (much of it by the same group) has found an increased risk of vascular problems in both men and women who experience migraines, especially those who experience migraine with visual symptoms known as aura.

One recent study found that women who suffer from migraines with aura are at higher risk of stroke, especially if they smoke and take oral contraceptives.

What's been missing, however, is data on how the frequency of migraines might affect cardiovascular risk.

This study involved almost 28,000 female health professionals in the United States aged 45 and older, none of whom had cardiovascular disease when the trial started.

During about 12 years of follow-up, and compared to women with no migr
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Epilepsy Drug Doesnt Prevent Migraines
2. Comatose locusts may help relieve migraines
3. Neuromuscular Dentistry Ends Womans Migraines
4. Study shows that high-dose, high-frequency interferon produces no additional benefit
5. JCSM: A high frequency of sleep-related breathing disorders in hospitalized patients
6. Hormone therapy increases frequency of abnormal mammograms, breast biopsies
7. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
8. Optical frequency comb can detect the breath of disease
9. Where vets served affects frequency of ER visits but not hospital stays
10. US hospitals report infections increasing in frequency and cost
11. Neighborhood Influences Exercise Levels
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Migraines' Frequency Influences Heart Attack, Stroke Risk
Migraines' Frequency Influences Heart Attack, Stroke Risk
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
...icials across UK are participating in a dummy exer...y bird flu pandemic. The preparation may be s...n Britain are wary of a bird flu epidemic hitting ... chiefly in birds, but infections with these virus...
...s have developed an experimental vaccine that redu...d with cytomegalovirus// (CMV). This virus also ca...n children infected in early fetal life. The Natio... no vaccine or treatment for pregnant women who ha...
...er Anoushka Shankar has become the first Indian ce...o fight against hunger in India//. She joins...ollywood star Drew Barrymore and footballer Ronald...ause. I will personally do whatever I can to raise...
... a haven for migratory birds, is gearing up to tac...ases// of the deadly virus. "We are watching...industry to take certain protective measures," sai...lu had been reported yet from any part of the stat...
...ounterfeit drugs are being circulated in South Asi...ingitis, typhoid//, pneumonia and avian flu. Accor...iane, the drugs have been well disguised making it... treated with the original drug. They also add tha...
...to a report released by International Federation o...a has been hit by measles//. This disease has so f...people are said to be affected by this illness. ... cases pointing to the spread of the disease. The ...
Other Medicine News:Health News:Dummy Emergency Operation Launched 2Health News:CMV Vaccine Prototype Successfully Tested in Guinea Pigs 2Health News:CMV Vaccine Prototype Successfully Tested in Guinea Pigs 3
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
(Date:12/3/2009)FORT WORTH, Texas, Dec. 3 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health In
Breaking Medicine Technology:Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3West Announces Third Quarter 2009 Results 5943 1West Announces Third Quarter 2009 Results 5943 2West Announces Third Quarter 2009 Results 5943 3West Announces Third Quarter 2009 Results 5943 4West Announces Third Quarter 2009 Results 5943 5West Announces Third Quarter 2009 Results 5943 6West Announces Third Quarter 2009 Results 5943 7West Announces Third Quarter 2009 Results 5943 8West Announces Third Quarter 2009 Results 5943 9West Announces Third Quarter 2009 Results 5943 10West Announces Third Quarter 2009 Results 5943 11West Announces Third Quarter 2009 Results 5943 12West Announces Third Quarter 2009 Results 5943 13West Announces Third Quarter 2009 Results 5943 14West Announces Third Quarter 2009 Results 5943 15West Announces Third Quarter 2009 Results 5943 16West Announces Third Quarter 2009 Results 5943 17West Announces Third Quarter 2009 Results 5943 18West Announces Third Quarter 2009 Results 5943 19West Announces Third Quarter 2009 Results 5943 20West Announces Third Quarter 2009 Results 5943 21West Announces Third Quarter 2009 Results 5943 22Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 1Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 2Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 3Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 4Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 5Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 6Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 7Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 8Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 9Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 10Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 11Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 12Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 13Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 14Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 15Regeneron Reports Third Quarter 2009 Financial and Operating Results 5939 16Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 1Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 2Experimental Stem Cell Therapy Raises Hope for Pulmonary Fibrosis Patients 14698 3
...48-week investigational regimen yielded nearly dou...ate on next-generation HCV protease inhibitor SCH ...HAGEN, Denmark, April 23 Schering-Plough Corporat...ts of the HCV SPRINT-1 study showed boceprevir, it...tor, in combination with peginterferon alfa-2b and...
... , , , FDA approval for testing in humans water..., , ROCKVILLE, Md., April 23 In a move that high...n in tackling international health challenges, the... from the PATH Malaria Vaccine Initiative (MVI), h... tests in adult volunteers -- of its unique malari...
Other Medicine Technology:Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 2Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 3Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 4
...G-9200 is a Windows 2000 PC based EEG with high pe... and software. EEG-9200 provides high quality perf...in the sleep lab or EEG lab. Quality EEG recording...CU. Neurofax has high performance, high sensitivit...
...act is the first magnetic stimulator to offer the ... stimulation. It is designed to provide the simple...tic routine (at the same time, it may also help re...ons without moving away from your patient). , ,...
Fidelity IAB Intra-Aortic Balloon Catheter
...series is a new top-line range of digital pacemake...rillation (AF). Because the T-series combines digi...reatment of AF is taken one step further. Thanks t...ored continuously and extensively. This gives phys...
Medicine Products: